Cargando…

A single dose of African horse sickness virus (AHSV) VP2 based vaccines provides complete clinical protection in a mouse model

African horse sickness is a severe, often fatal, arboviral disease of equids. The control of African horse sickness virus (AHSV) in endemic countries is based currently on the use of live attenuated vaccines despite some biosafety concerns derived from its biological properties. Thus, experimental v...

Descripción completa

Detalles Bibliográficos
Autores principales:	Aksular, Mine, Calvo-Pinilla, Eva, Marín-López, Alejandro, Ortego, Javier, Chambers, Adam C., King, Linda A., Castillo-Olivares, Javier
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Science 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6219453/ https://www.ncbi.nlm.nih.gov/pubmed/30309744 http://dx.doi.org/10.1016/j.vaccine.2018.09.065

Ejemplares similares

A Modified Vaccinia Ankara Virus (MVA) Vaccine Expressing African Horse Sickness Virus (AHSV) VP2 Protects Against AHSV Challenge in an IFNAR −/− Mouse Model
por: Castillo-Olivares, Javier, et al.
Publicado: (2011)

Antiserum from mice vaccinated with modified vaccinia Ankara virus expressing African horse sickness virus (AHSV) VP2 provides protection when it is administered 48 h before, or 48 h after challenge
por: Calvo-Pinilla, Eva, et al.
Publicado: (2015)

The immunogenicity of recombinant vaccines based on modified Vaccinia Ankara (MVA) viruses expressing African horse sickness virus VP2 antigens depends on the levels of expressed VP2 protein delivered to the host
por: Calvo-Pinilla, Eva, et al.
Publicado: (2018)

VP2 Exchange and NS3/NS3a Deletion in African Horse Sickness Virus (AHSV) in Development of Disabled Infectious Single Animal Vaccine Candidates for AHSV
por: van de Water, Sandra G. P., et al.
Publicado: (2015)

Induction of Antibody Responses to African Horse Sickness Virus (AHSV) in Ponies after Vaccination with Recombinant Modified Vaccinia Ankara (MVA)
por: Chiam, Rachael, et al.
Publicado: (2009)

Reverse genetics approaches: a novel strategy for African horse sickness virus vaccine design
por: Calvo-Pinilla, Eva, et al.
Publicado: (2020)

Ns1 Is a Key Protein in the Vaccine Composition to Protect Ifnar(−/−) Mice against Infection with Multiple Serotypes of African Horse Sickness Virus
por: de la Poza, Francisco, et al.
Publicado: (2013)

Requirements and comparative analysis of reverse genetics for bluetongue virus (BTV) and African horse sickness virus (AHSV)
por: van Rijn, Piet A., et al.
Publicado: (2016)

Vaccination of horses with a recombinant modified vaccinia Ankara virus (MVA) expressing African horse sickness (AHS) virus major capsid protein VP2 provides complete clinical protection against challenge
por: Alberca, Berta, et al.
Publicado: (2014)

African horse sickness in Thailand: Challenges of controlling an outbreak by vaccination
por: Castillo‐Olivares, Javier
Publicado: (2020)

Assessment of reproducibility of a VP7 Blocking ELISA diagnostic test for African horse sickness
por: Durán‐Ferrer, Manuel, et al.
Publicado: (2018)

Pathological features of African horse sickness virus infection in IFNAR(−/−) mice
por: Jones, Luke M., et al.
Publicado: (2023)

Immunogenicity of recombinant VP2 proteins of all nine serotypes of African horse sickness virus
por: Kanai, Yuta, et al.
Publicado: (2014)

Investigating the Role of African Horse Sickness Virus VP7 Protein Crystalline Particles on Virus Replication and Release
por: Bekker, Shani, et al.
Publicado: (2022)

Real Time RT-PCR Assays for Detection and Typing of African Horse Sickness Virus
por: Bachanek-Bankowska, Katarzyna, et al.
Publicado: (2014)

Generation of a Soluble African Horse Sickness Virus VP7 Protein Capable of Forming Core-like Particles
por: Bekker, Shani, et al.
Publicado: (2022)

Clinical, Virological and Immunological Responses after Experimental Infection with African Horse Sickness Virus Serotype 9 in Immunologically Naïve and Vaccinated Horses
por: Durán-Ferrer, Manuel, et al.
Publicado: (2022)

CD8 T Cell Responses to an Immunodominant Epitope within the Nonstructural Protein NS1 Provide Wide Immunoprotection against Bluetongue Virus in IFNAR(−/−) Mice
por: Marín-López, Alejandro, et al.
Publicado: (2018)

Protection of IFNAR (−/−) Mice against Bluetongue Virus Serotype 8, by Heterologous (DNA/rMVA) and Homologous (rMVA/rMVA) Vaccination, Expressing Outer-Capsid Protein VP2
por: Jabbar, Tamara Kusay, et al.
Publicado: (2013)

Immune response of horses to inactivated African horse sickness vaccines
por: Rodríguez, Marina, et al.
Publicado: (2020)

Evidence of Intragenic Recombination in African Horse Sickness Virus
por: Ngoveni, Harry G., et al.
Publicado: (2019)

African Horse Sickness Virus Serotype 1 on Horse Farm, Thailand, 2020
por: Bunpapong, Napawan, et al.
Publicado: (2021)

Pathological Characterization Of IFNAR(-/-) Mice Infected With Bluetongue Virus Serotype 4
por: Marín-López, Alejandro, et al.
Publicado: (2016)

Comparative immune responses after vaccination with the formulated inactivated African horse sickness vaccine serotype 1 between naïve horses and pretreated horses with the live-attenuated African horse sickness vaccine
por: Chaiyabutr, Narongsak, et al.
Publicado: (2022)

Safety and immunogenicity of plant-produced African horse sickness virus-like particles in horses
por: Dennis, Susan J., et al.
Publicado: (2018)

A review of African horse sickness and its implications for Ireland
por: Thompson, Geoffrey M, et al.
Publicado: (2012)

Seroprevalence of African horse sickness in selected donkey populations in Namibia
por: Molini, Umberto, et al.
Publicado: (2020)

Addressing the recent outbreak of African horse sickness in Lagos, Nigeria
por: Adesola, Ridwan Olamilekan, et al.
Publicado: (2023)

Horse Sickness
por: Smith, W. Ramsey
Publicado: (1902)

Quantitative Risk Assessment for African Horse Sickness in Live Horses Exported from South Africa
por: Sergeant, Evan S., et al.
Publicado: (2016)

Transmission and Control of African Horse Sickness in The Netherlands: A Model Analysis
por: Backer, Jantien A., et al.
Publicado: (2011)

Re-emergence of bluetongue, African horse sickness, and other Orbivirus diseases
por: MacLachlan, N. James, et al.
Publicado: (2010)

Adaptive strategies of African horse sickness virus to facilitate vector transmission
por: Wilson, Anthony, et al.
Publicado: (2009)

African Horse Sickness: A Review of Current Understanding and Vaccine Development
por: Dennis, Susan J, et al.
Publicado: (2019)

Development of a Novel Reverse Transcription Loop‐Mediated Isothermal Amplification Assay for the Rapid Detection of African Horse Sickness Virus
por: Fowler, V. L., et al.
Publicado: (2016)

Sero-epidemioloical survey on African horse sickness virus among horses in Khartoum State, Central Sudan
por: Karamalla, Siham T., et al.
Publicado: (2018)

B-cell epitopes of African horse sickness virus serotype 4 recognised by immune horse sera
por: Mathebula, Evans M., et al.
Publicado: (2017)

Modeling Arboviral Infection in Mice Lacking the Interferon Alpha/Beta Receptor
por: Marín-Lopez, Alejandro, et al.
Publicado: (2019)

Characterising Non-Structural Protein NS4 of African Horse Sickness Virus
por: Zwart, Lizahn, et al.
Publicado: (2015)

Seroprevalence and Risk Factors of African Horse Sickness in Three Agroecological Zones of Cameroon
por: Ndebé, Mohamed M. F., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_6o0lvef2v22rsr5eps2jqq3a31